{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:05:06Z","timestamp":1789099506545,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Malignant acral melanoma (AM) is relatively infrequent in white patients. Molecular investigations have returned variable results regarding the mutational pattern. We sought to describe the mutation profile and clinicopathologic features of AM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We investigated BRAF, KIT, and NRAS mutational status in a series of 31 AM samples from white patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Nodular melanoma was the most common histopathologic subtype (48.4%), followed by acral lentiginous melanoma (25.8%) and superficial spreading melanoma (25.8%). BRAF, KIT, and NRAS mutational rates were 12.9%, 17.2%, and 30.0%, respectively. We observed significant associations between KIT mutational status and a thinner Breslow thickness compared with wild-type (WT) status (P = .002), NRAS mutation status and younger age compared with WT. In patients presenting at least one mutation, triple-WT patients presented metastases most frequently.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although these data represent preliminary results, better knowledge of tumor biology and prognosis of AM can support the clinical approach and follow-up.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqz209","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T12:11:21Z","timestamp":1576066281000},"page":"664-671","source":"Crossref","is-referenced-by-count":41,"title":["BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients"],"prefix":"10.1093","volume":"153","author":[{"given":"Emi","family":"Dika","sequence":"first","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6595-7776","authenticated-orcid":false,"given":"Giulia","family":"Veronesi","sequence":"first","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Altimari","sequence":"first","affiliation":[{"name":"Laboratory of Oncologic and Transplantation Molecular Pathology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Riefolo","sequence":"first","affiliation":[{"name":"Laboratory of Oncologic and Transplantation Molecular Pathology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Maria","family":"Ravaioli","sequence":"first","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Maria","family":"Piraccini","sequence":"first","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lambertini","sequence":"first","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campione","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gruppioni","sequence":"first","affiliation":[{"name":"Laboratory of Oncologic and Transplantation Molecular Pathology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"first","affiliation":[{"name":"Laboratory of Oncologic and Transplantation Molecular Pathology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Melotti","sequence":"first","affiliation":[{"name":"Medical Oncology Unit, Sant\u2019Orsola Malpighi Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ferracin","sequence":"first","affiliation":[{"name":"Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Patrizi","sequence":"first","affiliation":[{"name":"Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"key":"2020041521554279500_CIT0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-319-22539-5_14","article-title":"Acral lentiginous melanoma","volume":"167","author":"Goydos","year":"2016","journal-title":"Cancer Treat Res."},{"key":"2020041521554279500_CIT0002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMc1706162","article-title":"Acral melanoma and mechanical stress on the plantar surface of the foot","volume":"377","author":"Costello","year":"2017","journal-title":"N Engl J Med."},{"key":"2020041521554279500_CIT0003","article-title":"Rawson RV, Johansson PA, Hayward NK, et al. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas. Lab Invest. 2017;97:130-145."},{"key":"2020041521554279500_CIT0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.07.017","article-title":"Distinct genomic features in a retrospective cohort of mucosal, acral and vulvovaginal melanomas","author":"Shi","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"2020041521554279500_CIT0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/ced.13323","article-title":"Acral melanoma foot lesions, part 2: clinical presentation, diagnosis, and management","volume":"43","author":"Desai","year":"2018","journal-title":"Clin Exp Dermatol."},{"key":"2020041521554279500_CIT0006","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.jaad.2017.11.051","article-title":"Multiple digit melanonychia: examine the scalp","volume":"78","author":"Lambertini","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"2020041521554279500_CIT0007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archdermatol.2011.136","article-title":"Revised 3-step dermoscopic algorithm for the management of acral melanocytic lesions","volume":"147","author":"Koga","year":"2011","journal-title":"Arch Dermatol."},{"key":"2020041521554279500_CIT0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1346-8138.2010.01174.x","article-title":"Key points in dermoscopic differentiation between early acral melanoma and acral nevus","volume":"38","author":"Saida","year":"2011","journal-title":"J Dermatol."},{"key":"2020041521554279500_CIT0009","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/exd.13321","article-title":"Mutational profiling of acral melanomas in Korean populations","volume":"26","author":"Shim","year":"2017","journal-title":"Exp Dermatol."},{"key":"2020041521554279500_CIT0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.2007.08031.x","article-title":"Acral lentiginous melanoma: histopathological prognostic features of 121 cases","volume":"157","author":"Phan","year":"2007","journal-title":"Br J Dermatol."},{"key":"2020041521554279500_CIT0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.2000.03651.x","article-title":"Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients","volume":"143","author":"Kuchelmeister","year":"2000","journal-title":"Br J Dermatol."},{"key":"2020041521554279500_CIT0012","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-4362.1999.00736.x","article-title":"Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period","volume":"38","author":"Kato","year":"1999","journal-title":"Int J Dermatol."},{"key":"2020041521554279500_CIT0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2559.1991.tb00232.x","article-title":"Subungual malignant melanoma: clinicopathological features of 100 cases","volume":"19","author":"Blessing","year":"1991","journal-title":"Histopathology."},{"key":"2020041521554279500_CIT0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2133.1993.tb15138.x","article-title":"Plantar malignant melanoma in a white Caucasian population","volume":"128","author":"Dwyer","year":"1993","journal-title":"Br J Dermatol."},{"key":"2020041521554279500_CIT0015","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1158\/1078-0432.CCR-05-2447","article-title":"Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies","volume":"12","author":"Saldanha","year":"2006","journal-title":"Clin Cancer Res."},{"key":"2020041521554279500_CIT0016","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/1078-0432.CCR-10-2346","article-title":"Large-scale analysis of KIT aberrations in Chinese patients with melanoma","volume":"17","author":"Kong","year":"2011","journal-title":"Clin Cancer Res."},{"key":"2020041521554279500_CIT0017","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jmoldx.2012.10.002","article-title":"Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma","volume":"15","author":"Greaves","year":"2013","journal-title":"J Mol Diagn."},{"key":"2020041521554279500_CIT0018","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res."},{"key":"2020041521554279500_CIT0019","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jdermsci.2013.07.013","article-title":"KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma","volume":"72","author":"Zebary","year":"2013","journal-title":"J Dermatol Sci."},{"key":"2020041521554279500_CIT0020","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/pcmr.12123","article-title":"KIT, NRAS, and BRAF mutations in nail apparatus melanoma","volume":"26","author":"Dika","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"2020041521554279500_CIT0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0022-202X.2004.22722.x","article-title":"BRAF point mutations in primary melanoma show different prevalences by subtype","volume":"123","author":"Sasaki","year":"2004","journal-title":"J Invest Dermatol."},{"key":"2020041521554279500_CIT0022","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"2020041521554279500_CIT0023","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol."},{"key":"2020041521554279500_CIT0024","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med."},{"key":"2020041521554279500_CIT0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CMR.0b013e3282f32517","article-title":"Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma","volume":"18","author":"Akslen","year":"2008","journal-title":"Melanoma Res."},{"key":"2020041521554279500_CIT0026","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","article-title":"Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","volume":"22","author":"Torres-Cabala","year":"2009","journal-title":"Mod Pathol."},{"key":"2020041521554279500_CIT0027","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA."},{"key":"2020041521554279500_CIT0028","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/jid.2010.405","article-title":"BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han","volume":"131","author":"Qi","year":"2011","journal-title":"J Invest Dermatol."},{"key":"2020041521554279500_CIT0029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2011.06.056","article-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","volume":"48","author":"Si","year":"2012","journal-title":"Eur J Cancer."},{"key":"2020041521554279500_CIT0030","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ejca.2012.02.049","article-title":"Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations","volume":"48","author":"Schoenewolf","year":"2012","journal-title":"Eur J Cancer."},{"key":"2020041521554279500_CIT0031","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2012.03.005","article-title":"Assessment of BRAF and KIT mutations in Japanese melanoma patients","volume":"66","author":"Ashida","year":"2012","journal-title":"J Dermatol Sci."},{"key":"2020041521554279500_CIT0032","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4132\/KoreanJPathol.2012.46.3.246","article-title":"Frequency of BRAF mutation and clinical relevance for primary melanomas","volume":"46","author":"Lee","year":"2012","journal-title":"Korean J Pathol."},{"key":"2020041521554279500_CIT0033","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin Cancer Res."},{"key":"2020041521554279500_CIT0034","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/exd.12080","article-title":"Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma","volume":"22","author":"Puig-Butill\u00e9","year":"2013","journal-title":"Exp Dermatol."},{"key":"2020041521554279500_CIT0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-0463.2011.02737.x","article-title":"KIT amplification and gene mutations in acral\/mucosal melanoma in Korea","volume":"119","author":"Yun","year":"2011","journal-title":"APMIS."},{"issue":":546","key":"2020041521554279500_CIT0036","article-title":"Frequent occurrence of NRAS and BRAF mutations in human acral naevi","volume":"11","author":"Jansen","year":"2019","journal-title":"Cancers."},{"key":"2020041521554279500_CIT0037","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00292-016-0260-y","article-title":"Diagnostics of malignant melanoma of the skin: recommendations of the current S3 guidelines on histology and molecular pathology","volume":"38","author":"Rose","year":"2017","journal-title":"Pathologe."},{"key":"2020041521554279500_CIT0038","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2012.338","article-title":"BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas","volume":"133","author":"Jin","year":"2013","journal-title":"J Invest Dermatol."},{"key":"2020041521554279500_CIT0039","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jid.2017.08.022","article-title":"Distinct patterns of acral melanoma based on site and relative sun exposure","volume":"138","author":"Haugh","year":"2018","journal-title":"J Invest Dermatol."},{"key":"2020041521554279500_CIT0040","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0190-9622(87)70291-6","article-title":"Drug-induced photo-onycholysis: three subtypes identified in a study of 15 cases","volume":"17","author":"Baran","year":"1987","journal-title":"J Am Acad Dermatol."},{"key":"2020041521554279500_CIT0041","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/15569527.2012.740118","article-title":"Nail apparatus melanoma: is trauma a coincidence? Is this peculiar tumor a real acral melanoma?","volume":"32","author":"Fanti","year":"2013","journal-title":"Cutan Ocul Toxicol."},{"key":"2020041521554279500_CIT0042","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.soc.2014.12.001","article-title":"Current staging and prognostic factors in melanoma","volume":"24","author":"Bartlett","year":"2015","journal-title":"Surg Oncol Clin N Am."},{"key":"2020041521554279500_CIT0043","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/labinvest.2016.147","article-title":"Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features","volume":"97","author":"Merkel","year":"2017","journal-title":"Lab Invest."},{"key":"2020041521554279500_CIT0044","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CMR.0000000000000222","article-title":"Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas","volume":"26","author":"Vazquez","year":"2016","journal-title":"Melanoma Res."},{"key":"2020041521554279500_CIT0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome Res."},{"key":"2020041521554279500_CIT0046","first-page":"134","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients","volume":"7","author":"Roh","year":"2017","journal-title":"Am J Cancer Res."},{"key":"2020041521554279500_CIT0047","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1158\/1078-0432.CCR-13-1266","article-title":"Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib","volume":"19","author":"Dai","year":"2013","journal-title":"Clin Cancer Res."},{"key":"2020041521554279500_CIT0048","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmoldx.2013.10.009","article-title":"TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization","volume":"16","author":"Diaz","year":"2014","journal-title":"J Mol Diagn."},{"key":"2020041521554279500_CIT0049","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature25187","article-title":"High response rate to PD-1 blockade in desmoplastic melanomas","volume":"553","author":"Eroglu","year":"2018","journal-title":"Nature."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/153\/5\/664\/33049430\/aqz209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/153\/5\/664\/33049430\/aqz209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T01:56:05Z","timestamp":1587002165000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/153\/5\/664\/5722364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,2,4]]},"published-print":{"date-parts":[[2020,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqz209","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,2,4]]}}}